EGFR and lung adenocarcinoma: The study conducted in China with 747 patients showed a slightly higher mutation with an overall EGFR mutation rate of 50% vs active EGFR mutation rate of 48% among their stage IIIb/IV lung adenocarcinoma patients [20].